At the conclusion of this activity, learners will be able to:
1) understand and appreciate the relationship between marijuana and synthetic cannabinoid use and the onset of psychiatric illness
2) appreciate the dilemma created by the legalization of "medical marijuana" and how this trend has legitimized marijuana use among teenagers
3) understand why teenagers are most at-risk, in relation to the general population, for marijuana-induced psychiatric illness
Professional practice gap to be addressed: These is widespread unawareness among the medical community with regard to the extent of adolescent substance abuse, cannabinoids and synthetic cannabinoids in particular, and co-morbid or subsequent development of psychiatric illness as teens and young adults. This presentation is designed to increase provider awareness of the facts and accompanying misassumptions with regard to marijuana and synthetic cannabinoid usage so as to improve practice patterns and enhance preventive efforts in the primary care realm.
Target audience: Physicians, mid-level providers, nurses, health care administrators